Home

Sandra L Hatten

CIK 1600771 · See Remarks · last filed 2019-12-16

Sandra L Hatten is a corporate insider who has filed 20 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing shows the insider sold $22.2K of AVDL on Dec 16, 2019. Across all open-market trades the lifetime net is −$227.4K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

20

Lifetime Open-Market Net

-$227.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVADEL PHARMACEUTICALS PLC (AVDL) Delisted See Remarks 59,165 $21.64 $1.28M -$5.7K 8 2019-12-16
AVADEL PHARMACEUTICALS PLC (FLML) Delisted See Remarks 0 — — $33.0K 6 2017-01-03
Keenova Therapeutics plc (MNK) Delisted Sr. VP, Quality 7,103 $0.34 $2.4K -$254.7K 6 2015-05-12

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-12-16 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Sell (S) −3,072 -$22.2K EDGAR
2019-03-11 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +18,000 $0 EDGAR
2018-12-18 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Sell (S) −3,173 -$8.2K EDGAR
2018-08-14 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Sell (S) −6,290 -$30.9K EDGAR
2017-12-14 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +12,500 $0 EDGAR
2017-09-15 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Buy (P) +6,000 $55.5K EDGAR
2017-02-24 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +35,200 $0 EDGAR
2017-01-13 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +33,000 $0 EDGAR
2017-01-03 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Disp (D) −33,000 $0 EDGAR
2017-01-03 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Grant (A) +33,000 $0 EDGAR
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.